Method for preparing imidazo [1, 2-a] pyrrolo [2, 3-e] pyrazine compound and solid-state form thereof

The present invention relates to a process for the preparation of (3S, 4R)-3-ethyl-4-(3H-imidazo [1, 2-A] pyrrolo [2, 3-E] pyrazin-8-yl)-N-(2, 2, 2-trifluoroethyl) pyrrolidine-1-carboxamide and solid state forms thereof. The present disclosure relates to methods for the preparation of (3S, 4R)-3-eth...

Full description

Saved in:
Bibliographic Details
Main Authors ALLIAN AYMAN D, OTHMAN AHMED A, BORCHARDT THOMAS B, NORDSTROEM FREDRIK LARS, BHAGAVATULA LAKSHMINARAYANA, MOHAMED MOHAMED-ESLAM F, COLLENDER BRIAN, MAYER PETER T, GAYENS JOHN, MULHERN MATHEW M, MARROUM PATRICK J, SHEIKH AHMAD Y, ROZEMA MICHAEL J
Format Patent
LanguageChinese
English
Published 23.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to a process for the preparation of (3S, 4R)-3-ethyl-4-(3H-imidazo [1, 2-A] pyrrolo [2, 3-E] pyrazin-8-yl)-N-(2, 2, 2-trifluoroethyl) pyrrolidine-1-carboxamide and solid state forms thereof. The present disclosure relates to methods for the preparation of (3S, 4R)-3-ethyl-4-(3H-imidazo [1, 2-a] pyrrolo [2, 3-e] pyrazin-8-yl)-N-(2, 2, 2-trifluoroethyl) pyrrolidine-1-carboxamide, solid state forms thereof, and corresponding pharmaceutical compositions, methods of treatment, including the treatment of rheumatoid arthritis, kits, methods of synthesis, and products characterized by the methods. 本发明涉及制备(3S,4R)-3-乙基-4-(3H-咪唑并[1,2-A]吡咯并[2,3-E]吡嗪-8-基)-N-(2,2,2-三氟乙基)吡咯烷-1-甲酰胺及其固态形式的方法。本披露涉及用于制备(3S,4R)-3-乙基-4-(3H-咪唑并[1,2-a]吡咯并[2,3-e]吡嗪-8-基)-N-(2,2,2-三氟乙基)吡咯烷-1-甲酰胺、其固态形式、和相应的药物组合物的方法、治疗(包括治疗类风湿性关节炎)的方法、试剂盒、合成方法、以及由方法表征的产品(products-by-process)。
Bibliography:Application Number: CN202211671778